Literature DB >> 18480972

An unusual case of pneumonia.

Primiano Iannone, Tiziano Lenzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18480972     DOI： 10.1007/s11739-008-0146-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  16 in total

1.  Mesalamine-induced unilateral eosinophilic pneumonia.

Authors:  K Saltzman; L J Rossoff; H Gouda; S Tongia
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

Review 2.  Rare extraintestinal manifestations of inflammatory bowel disease.

Authors:  R M Hoffmann; W Kruis
Journal:  Inflamm Bowel Dis       Date:  2004-03       Impact factor: 5.325

3.  Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.

Authors:  S Sviri; I Gafanovich; M R Kramer; E Tsvang; E Ben-Chetrit
Journal:  J Clin Gastroenterol       Date:  1997-01       Impact factor: 3.062

4.  Bronchiolitis obliterans organising pneumonia in a patient with ulcerative colitis.

Authors:  C R Swinburn; G J Jackson; I Cobden; T Ashcroft; G N Morritt; P A Corris
Journal:  Thorax       Date:  1988-09       Impact factor: 9.139

5.  Sulphasalazine-induced reversible hypersensitivity pneumonitis and fatal fibrosing alveolitis: report of two cases.

Authors:  R Leino; K Liippo; T Ekfors
Journal:  J Intern Med       Date:  1991-06       Impact factor: 8.989

6.  Bronchial disease in ulcerative colitis.

Authors:  T Higenbottam; G M Cochrane; T J Clark; D Turner; R Millis; W Seymour
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

7.  Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.

Authors:  K R Herrlinger; M K Noftz; K Dalhoff; D Ludwig; E F Stange; K Fellermann
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

Review 8.  Mesalazine-induced eosinophilic pneumonia.

Authors:  K Tanigawa; K Sugiyama; H Matsuyama; H Nakao; K Kohno; Y Komuro; Y Iwanaga; K Eguchi; M Kitaichi; H Takagi
Journal:  Respiration       Date:  1999       Impact factor: 3.580

9.  Large airway disease associated with inflammatory bowel disease.

Authors:  A Spira; R Grossman; M Balter
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

10.  Mesalazine: a global safety evaluation.

Authors:  R Brimblecombe
Journal:  Scand J Gastroenterol Suppl       Date:  1990
View more
  1 in total

1.  Gastroenterology case report of mesalazine-induced cardiopulmonary hypersensitivity.

Authors:  José Ferrusquía; Isabel Pérez-Martínez; Ricardo Gómez de la Torre; María Luisa Fernández-Almira; Ruth de Francisco; Luis Rodrigo; Sabino Riestra
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.